/ mrgm_fr

Today marked the kick-off meeting of the ANKIAL Pharma – ERDERA collaborative project, dedicated to advancing mitochondrial anti-hypertrophy therapy for selected rare diseases including Costello and Noonan syndromes.
We are grateful for ERDERA’s support, which is instrumental in fostering this ambitious international collaboration and increasing the visibility of research aimed at developing innovative treatments for patients with rare diseases.

Inserm Département Sciences Biologiques et Médicales Université de Bordeaux SATT Aquitaine Science Transfert Serge ARNOULET MRGM : Maladies Rares Génétiques et Métabolisme CELLOMET PhysioStim Délégation Inserm Nouvelle-Aquitaine SPARK-Bordeaux Région Nouvelle-Aquitaine ADERA Didier Lacombe Bruno Le Grand (PhD) Jonathan CHRIQUI Nivea Dias Amoedo Fondation Maladies Rares Fondation pour la Recherche Médicale